我院XX～XX年辅助用药注射剂使用分析.docxVIP

我院XX～XX年辅助用药注射剂使用分析 　　[摘要] 目的 了解常熟市第一人民医院辅助用药应用现状和趋势，为临床合理用药提供参考。 方法 依据江苏省苏州市及南京市卫计委辅助用药重点监控目录，从我院HIS中调取XX～XX年辅助用药注射剂相关数据，按照WHO推荐的限定日剂量法，对辅助用药注射剂的销售金额、年增长率、用药频度、排序比和限定日费用等进行统计分析。 结果 3年期间，我院辅助用药注射剂的销售金额分别为、、万元，XX、XX年各比上年下降%和%，占医院药品销售总金额的比例为%、%和%。销售金额和DDDs排序第1、2位类别是神经系统用药和免疫调节药。单品种销售金额排序列前3位的有神经节苷脂、鼠神经生长因子和依达拉奉等；单品种用药频度排序列前3位的是香菇多糖、脂溶性维生素和前列地尔。 结论 我院辅助用药注射剂使用大幅下降，管控成效显著。但仍需对性价比较差的辅助用药进行重点跟踪，进一步促进其合理使用。　　[关键词] 辅助用药注射剂；销售金额；用药频度；限定日费用；年增长率；合理用药　　[中图分类号] R288 [文献标识码] A [文章编号] 1673--0127-05　　[Abstract] Objective To understand the current situation and development trend of the adjuvant drug injections in Changshu People′s Hospital ， so as to provide reference for clinical rational use of the drugs. Methods According to the key monitoring directory of adjuvant drug injections issued by Suzhou and Nanjing Health and Family Planning Commission of Jiangsu Province， the relevant data of adjuvant drug injection from XX to XX was collected from HIS. The consumption sum， annual growth rate， defined daily dose system ， sorting ratio and defined daily cost of the adjuvant drug injections were statistically analyzed according to the limited daily dose recommend to WHO. Results During 3 years， the consumption sum of adjuvant drug injections each were ， and million yuan. The consumption sum of adjuvant drug injections of XX and XX declined by % and % compared with last year. The proportion of consumption sum of adjuvant drug injections in all drugs were % in XX， % in XX and % in XX. The first and second categories of consumption sum and DDDs rank were neurological drugs and immunomodulating drugs. The top 3 varieties of single item of consumption sum were ganglioside， mouse nerve growth factor and Edaravone. The top 3 varieties of single item of DDDs were lentinan， fat-soluble vitamin and Alprostadil. Conclusion The use of adjuvant drug injections in our hospital has dropped drastically， and the effectiveness of management and control is remarkable. However， it still needs to